In case you missed it, Saturday the Myeloma Beacon ran a summary of important data released from the International Myeloma Workshop in Paris earlier this month.
Go to: The 2011 International Myeloma Workshop – Key Themes and Learnings, to review research news from the conference.
My focus has already shifted to the upcoming ASCO meetings in Chicago the first week in June. This weekend I focused on the exciting, new antibody, elotuzumab. I’m sure there will be a lot more “pre-ASCO” multiple myeloma related research news leaking out every day now. Stay tuned!
Feel good and keep smiling!